Policy

Lawmakers, governor approve bill allowing more scrutiny of health care deals.

The Institute for Healthcare Improvement unveils a four-step framework to help hospitals and practices measure inequities the same way, turning goals into actionable metrics.

Pfizer was at the White House late last month; AstraZeneca touts expansion in Virginia.

A new KFF survey finds that while 77% of Americans heard President Trump’s claim linking Tylenol use during pregnancy to autism, most aren’t convinced.

A KFF survey shows 77% of U.S. adults heard President Trump’s claim linking Tylenol use in pregnancy to autism. Most don’t believe it.

SullivanCotter’s 2025 survey finds executive compensation up 4.7% overall, with the fastest growth in operations, digital strategy and compliance leadership roles.

In part two of MJH Life Sciences’ three-part series, experts dissect President Trump’s most-favored nation executive order, warning that its use of tariffs and foreign price benchmarks could upend drug markets and test the limits of federal authority.

Ohio State researchers say the billionaire entrepreneur’s Cost Plus Drug Company exposes how insurance premiums and middlemen drive up the true cost of neurologic medications.

Kyle Zebley, senior VP of the American Telemedicine Association, joins the show to talk about the expiration of Medicare’s telehealth flexibilities during the October 2025 federal government shutdown.

A regional inspector general for the U.S. Department of Health and Human Services explains oversight of a multi-billion-dollar trend in Medicare spending.

As spending climbs and value plummets, Trilliant Health proposes hard questions to buck negative trends.

At the MGMA Leaders Conference 2025 in Orlando, Michael Blackman, M.D., MBA, chief medical officer of Greenway Health, sat down with Medical Economics to separate AI fact from fiction.

Michael Blackman, M.D., MBA, says rapid change and integration challenges still make adoption difficult for many practices.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

Kevin Schulman, M.D., MBA, professor of medicine at Stanford University, joins the show to talk about administrative burdens in health care.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert from the American Telemedicine Association offers his summary of what’s happening in Washington, D.C.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.

A policy expert of the American Telemedicine Association reacts to the suspension of flexibilities for telehealth care in traditional Medicare.